Impact of C34T P2Y12 ADP receptor polymorphism and smoking status on cardiovascular outcome in coronary artery disease patients receiving clopidogrel

International Journal of Cardiology

Volumn 210, Issue , 2016, Pages 161-163

  Siasos, Gerasimos ^a,b   Kioufis, Stamatios ^a   Oikonomou, Evangelos ^a   Zaromitidou, Marina ^a   Maniatis, Kostas ^a   Vavuranakis, Manolis ^a   Kokkou, Eleni ^a   Tousoulis, Dimitris ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ADP receptor polymorphism; Clopidogrel; Coronary artery disease; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y RECEPTOR ANTAGONIST; TICLOPIDINE;

ADULT; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC POLYMORPHISM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HETEROZYGOTE; HOMOZYGOTE; HOSPITALIZATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING; SURVIVAL RATE; TRANSIENT ISCHEMIC ATTACK; AGED; ANALOGS AND DERIVATIVES; FOLLOW UP; GENETICS; MIDDLE AGED; TREATMENT OUTCOME;

AGED; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; SMOKING; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84964690905     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.02.129     Document Type: Article

References (12)

1. M. Roffi, C. Patrono, J.P. Collet, and et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 37 2016 267 315
2. T. Heitzer, V. Rudolph, E. Schwedhelm, and et al. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects Arterioscler Thromb Vasc Biol 26 2006 1648 1652
3. M. Vavuranakis, K. Kalogeras, N. Dagres, and et al. Residual platelet reactivity after clopidogrel loading in ST-elevation myocardial infarction patients undergoing a delayed catheterization. Impact on long term clinical events Int J Cardiol 176 2014 1292 1293
4. G. Siasos, D. Tousoulis, and C. Stefanadis CYP2C19 genotype and outcomes of clopidogrel treatment N Engl J Med 364 2011 481 482
5. D.J. Angiolillo, E. Bernardo, M. Zanoni, and et al. Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease J Am Coll Cardiol 58 2011 30 39
6. G. Siasos, D. Tousoulis, and C. Stefanadis Multiple mechanisms affect the clopidogrel response J Am Coll Cardiol 53 2009 900 901
7. W. Hochholzer, D. Trenk, J.L. Mega, and et al. Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy Am Heart J 162 2011 518 526 (e515)
8. S. Matetzky, B. Shenkman, V. Guetta, and et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
9. K.P. Bliden, J. Dichiara, L. Lawal, and et al. The association of cigarette smoking with enhanced platelet inhibition by clopidogrel J Am Coll Cardiol 52 2008 531 533
10. P.A. Gurbel, K.P. Bliden, D.K. Logan, and et al. The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study J Am Coll Cardiol 62 2013 505 512
11. Ferreiro, J.L., Bhatt D. L., Ueno, M., Bauer, D., Angiolillo, D. J. Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events). J Am Coll Cardiol 63:769-777.
12. G. Shanker, J.L. Kontos, D.M. Eckman, D. Wesley-Farrington, and D.C. Sane Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts J Thromb Thrombolysis 22 2006 213 220